General Information
Version
4.0
Revision date
2026-02-19
Product name
4.0
Product name
4.0
Identification on the label/Trade name
DRBC Agar (ISO)
CAS No.
56-75-7
Manufacturer Name
Neogen Corporation
Emergency telephone
1-800-498-5743, 1-651-523-0318, 1-800-424-9300, 1-703-527-3887
Icons in SDS
Company Information
company name
Neogen Corporation
e-mail address of the competent person responsible for the Safety Data Sheet
sds@neogen.com, naa@neogen.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H313, H350
Hazard statements
Code
Statements
H313
May be harmful in contact with skin
Section 2
SECTION 2: Hazards identification
Classification according to the model Work Health and Safety Regulations (WHS Regulations) Classification of the hazardous chemical
Signal word
Danger
Contains
Potassium dihydrogenorthophosphate (≥ 1 – < 5 %); Chloramphenicol (≥ 0.1 – < 0.5 %)
Hazard statements
H313 - May be harmful in contact with skin H350 - May cause cancer
Precautionary statements
P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P312 - Call a POISON CENTER or doctor if you feel unwell. P405 - Store locked up. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
Ingredient(s) with unknown acute toxicity
15.75% of the mixture consists of ingredient(s) of unknown acute toxicity (Oral) 96.09% of the mixture consists of ingredient(s) of unknown acute toxicity (Dermal) 99.24% of the mixture consists of ingredient(s) of unknown acute toxicity (Inhalation (Dust/Mist))
Other hazards which do not result in classification
No additional information available
2.1 Classification of the substance or mixture
Classification according to the model Work Health and Safety Regulations (WHS Regulations) Acute toxicity (dermal), Category 5 H313 Carcinogenicity, Category 1B H350
